Satisfactory primary tetanus antitoxin responses but markedly reduced germinal centre formation in first draining lymph nodes of ageing mice. 1987

R Kraft, and M Bachmann, and K Bachmann, and H Buerki, and M W Hess, and H Cottier, and R D Stoner

The present report deals with primary antibody responses to tetanus toxoid in 50-54-week-old ('ageing') as compared to 8-9-week-old ('young adult') mice. Antitoxin in the serum appeared 6 days earlier in the older than in the young animals, but in the latter reached 5 times higher titres on day 20. The magnitude of the proliferative response in the paracortex and the medulla of popliteal lymph nodes, as estimated by combined 3H-thymidine autoradiography and planimetry, was 3-7 times greater in the younger than in the older age group, thus approximately reflecting the difference in antibody titres on day 20. In contrast, germinal centre formation in response to the stimulus proved to be about 14 times less in ageing than in young adult mice. The findings demonstrate that, in the model system used, the age-related slopes of decline in humoral antibody responsiveness and proliferative reactivity in paracortex and medulla of first regional lymph nodes tend to be in parallel, while the ability of the immune apparatus to form germinal centres at this site deteriorates at a considerably faster pace. Results are also in line with the notion that centroblasts/centrocytes contribute little, if anything, to the ongoing antibody production elicited by the same stimulus which had triggered germinal centre formation. Finally, the observations made disprove the general validity of the suggestion that immune reactivity is maintained on the same level throughout life if tested with a novel antigen.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D013743 Tetanus Antitoxin An antitoxin used for the treatment of TETANUS. Antitoxin, Tetanus
D013745 Tetanus Toxoid Tetanus Vaccine,Toxoid, Tetanus,Vaccine, Tetanus

Related Publications

R Kraft, and M Bachmann, and K Bachmann, and H Buerki, and M W Hess, and H Cottier, and R D Stoner
November 2023, Infection and immunity,
R Kraft, and M Bachmann, and K Bachmann, and H Buerki, and M W Hess, and H Cottier, and R D Stoner
November 1984, Archivum histologicum Japonicum = Nihon soshikigaku kiroku,
R Kraft, and M Bachmann, and K Bachmann, and H Buerki, and M W Hess, and H Cottier, and R D Stoner
September 2013, JAMA surgery,
R Kraft, and M Bachmann, and K Bachmann, and H Buerki, and M W Hess, and H Cottier, and R D Stoner
March 1986, Archivum histologicum Japonicum = Nihon soshikigaku kiroku,
R Kraft, and M Bachmann, and K Bachmann, and H Buerki, and M W Hess, and H Cottier, and R D Stoner
February 1992, International journal of experimental pathology,
R Kraft, and M Bachmann, and K Bachmann, and H Buerki, and M W Hess, and H Cottier, and R D Stoner
January 1982, Archives of dermatological research,
R Kraft, and M Bachmann, and K Bachmann, and H Buerki, and M W Hess, and H Cottier, and R D Stoner
January 1975, Neoplasma,
R Kraft, and M Bachmann, and K Bachmann, and H Buerki, and M W Hess, and H Cottier, and R D Stoner
December 2018, Cell reports,
R Kraft, and M Bachmann, and K Bachmann, and H Buerki, and M W Hess, and H Cottier, and R D Stoner
September 1953, The Yale journal of biology and medicine,
R Kraft, and M Bachmann, and K Bachmann, and H Buerki, and M W Hess, and H Cottier, and R D Stoner
January 2002, Annals of surgical oncology,
Copied contents to your clipboard!